Vienna, Austria

Heinz Burgmann

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sealife Pharma Gmbh. Active years: 2017.



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heinz Burgmann: Innovator in Bioactive Polymers

Introduction

Heinz Burgmann is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of bioactive polymers, showcasing his expertise through innovative patent work. His dedication to research and development has positioned him as a key figure in his industry.

Latest Patents

Heinz Burgmann holds a patent for bioactive polymers, specifically polycondensation products of aminoguanidine and/or 1,3-diaminoguanidine with one or more diamines. This patent includes polyguanidine derivatives characterized by specific chemical formulas. The production methods and applications of these polyguanidine derivatives are also detailed in his patent, highlighting their potential uses in various fields.

Career Highlights

Heinz Burgmann is associated with Sealife Pharma GmbH, where he continues to advance his research in bioactive materials. His work has led to the development of innovative solutions that address various challenges in the pharmaceutical and biomedical sectors. With a focus on practical applications, he aims to enhance the effectiveness of bioactive compounds.

Collaborations

Heinz has collaborated with notable colleagues, including Alexander Pretsch and Michael Nagl. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.

Conclusion

Heinz Burgmann's contributions to the field of bioactive polymers exemplify his commitment to innovation and research. His patent work and collaborations reflect a dedication to advancing technology for practical applications. His ongoing efforts continue to influence the landscape of bioactive materials.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…